Civica Invests $27.8 Million for a New Testing Facility

Civica, Inc., a nonprofit generic drug company, will invest $27.8 million to establish a new laboratory testing facility at Meadowville Technology Park in Chesterfield County, Virginia. The company will construct a 55,000-square-foot facility to support its Petersburg, Virginia pharmaceutical manufacturing operation through quality testing and development of new products. The project will create 51 new jobs.

The construction of the laboratory will be supported by an award from the U.S. Economic Development Administration to the Alliance for Building Better Medicine, a coalition that aims to expand essential medicines manufacturing in the Richmond-Petersburg region. Civica will provide matching capital.

Civica is a nonprofit generic drug company launched in 2018 to address the problem of chronic generic drug shortages and high drug prices. In January 2021, Civica announced that it will establish a 140,000-square-foot state-of-the-art facility to manufacture sterile injectable drugs in the City of Petersburg. The company’s new laboratory testing facility in Chesterfield County is expected to be operational soon after the Petersburg plant reaches commercial scale in 2024.